复发性-话题@MedSci

#复发性#

452篇内容 | 2450人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1909599, encodeId=ed931909599b2, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Stroke：卒中前危险因素可严重影响复发性卒中和卒中后痴呆症, objectType=article, longId=72889, objectId=c11fe2889b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c11fe2889b3, replyNumber=0, likeNumber=79, createdTime=2017-05-02, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c11fe2889b3, moduleTitle=Stroke：卒中前危险因素可严重影响复发性卒中和卒中后痴呆症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c11fe2889b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909595, encodeId=18001909595d2, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=【NCCN2016】复发性或转移性乳腺癌化疗方案汇总, objectType=article, longId=68495, objectId=f9826849581, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9826849581, replyNumber=0, likeNumber=61, createdTime=2016-08-02, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9826849581, moduleTitle=【NCCN2016】复发性或转移性乳腺癌化疗方案汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9826849581)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909593, encodeId=6c4d19095934f, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=JACC：下腔静脉过滤器可减少复发性肺栓塞患者的死亡率, objectType=article, longId=64645, objectId=7ac6646456f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ac6646456f, replyNumber=0, likeNumber=81, createdTime=2016-08-21, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ac6646456f, moduleTitle=JACC：下腔静脉过滤器可减少复发性肺栓塞患者的死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ac6646456f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909587, encodeId=a387190958e9a, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=NEJM：孕酮不能提高复发性流产女性的活产婴儿率, objectType=article, longId=59524, objectId=62585952429, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62585952429, replyNumber=0, likeNumber=102, createdTime=2016-10-16, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62585952429, moduleTitle=NEJM：孕酮不能提高复发性流产女性的活产婴儿率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62585952429)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909596, encodeId=bd301909596e3, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet：TIA或缺血性卒中后预防复发性卒中，越早服用阿司匹林越好, objectType=article, longId=68718, objectId=b9d468e1838, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9d468e1838, replyNumber=0, likeNumber=64, createdTime=2016-06-08, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9d468e1838, moduleTitle=Lancet：TIA或缺血性卒中后预防复发性卒中，越早服用阿司匹林越好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9d468e1838)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909589, encodeId=f80219095897a, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=招募患者：PD-1抗体（BMS-936558）在中国晚期或复发性实体瘤受试者中的I、II期、开放性临床研究, objectType=article, longId=61205, objectId=623a61205d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=623a61205d3, replyNumber=0, likeNumber=62, createdTime=2016-06-11, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=623a61205d3, moduleTitle=招募患者：PD-1抗体（BMS-936558）在中国晚期或复发性实体瘤受试者中的I、II期、开放性临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=623a61205d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909591, encodeId=66de190959137, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=JAMA：血压控制与复发性颅内出血, objectType=article, longId=63175, objectId=2716631e5f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2716631e5f1, replyNumber=0, likeNumber=91, createdTime=2016-12-23, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2716631e5f1, moduleTitle=JAMA：血压控制与复发性颅内出血, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2716631e5f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909586, encodeId=9e0b1909586b0, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet Haematology：复发性多发性骨髓瘤：Elotuzumab有良好的安全性和疗效性, objectType=article, longId=58894, objectId=8c0b5889437, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c0b5889437, replyNumber=0, likeNumber=72, createdTime=2016-04-03, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c0b5889437, moduleTitle=Lancet Haematology：复发性多发性骨髓瘤：Elotuzumab有良好的安全性和疗效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c0b5889437)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909592, encodeId=b04f1909592ef, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Stem Cells：女性复发性流产的元凶——缺乏干细胞, objectType=article, longId=64574, objectId=2ef4645e45d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ef4645e45d, replyNumber=0, likeNumber=103, createdTime=2016-06-19, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ef4645e45d, moduleTitle=Stem Cells：女性复发性流产的元凶——缺乏干细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ef4645e45d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909590, encodeId=385f190959075, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=FDA批准单抗药Arzerra治疗复发性CLL, objectType=article, longId=62378, objectId=cbef623e83a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbef623e83a, replyNumber=0, likeNumber=58, createdTime=2016-09-02, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbef623e83a, moduleTitle=FDA批准单抗药Arzerra治疗复发性CLL, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbef623e83a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909577, encodeId=ea3e19095e7a6, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=诺华白血病药物Arzerra III期临床显著改善复发性CLL无进展生存期, objectType=article, longId=52073, objectId=0df1520e32c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0df1520e32c, replyNumber=0, likeNumber=62, createdTime=2016-05-07, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0df1520e32c, moduleTitle=诺华白血病药物Arzerra III期临床显著改善复发性CLL无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0df1520e32c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909582, encodeId=7a6e190958236, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Neurology：高血压能够预测儿童癌症幸存者的复发性卒中？, objectType=article, longId=56605, objectId=187f56605ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=187f56605ae, replyNumber=0, likeNumber=69, createdTime=2016-08-13, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=187f56605ae, moduleTitle=Neurology：高血压能够预测儿童癌症幸存者的复发性卒中？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=187f56605ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909579, encodeId=6b9219095e91c, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=复发性/难治性多发性骨髓瘤患者的福音：Elotuzumab疗法, objectType=article, longId=55116, objectId=9ff455116d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ff455116d1, replyNumber=0, likeNumber=79, createdTime=2016-04-03, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ff455116d1, moduleTitle=复发性/难治性多发性骨髓瘤患者的福音：Elotuzumab疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ff455116d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909574, encodeId=636319095e483, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=JAMA：产毒艰难梭菌菌株M3有效预防复发性艰难梭菌感染（CDI）, objectType=article, longId=50327, objectId=72095032ed3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72095032ed3, replyNumber=0, likeNumber=58, createdTime=2015-12-16, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72095032ed3, moduleTitle=JAMA：产毒艰难梭菌菌株M3有效预防复发性艰难梭菌感染（CDI）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72095032ed3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909575, encodeId=497519095e5af, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=JAMA Inter Med：华法林治疗中断后复发性静脉血栓栓塞、出血和死亡风险, objectType=article, longId=51333, objectId=10d35133372, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10d35133372, replyNumber=0, likeNumber=85, createdTime=2015-06-01, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10d35133372, moduleTitle=JAMA Inter Med：华法林治疗中断后复发性静脉血栓栓塞、出血和死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10d35133372)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909578, encodeId=633919095e8b3, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet Haematology：硼替佐米联合帕比司他治疗复发性或难治性外周T细胞淋巴瘤, objectType=article, longId=53073, objectId=5090530e3a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5090530e3a5, replyNumber=0, likeNumber=95, createdTime=2015-12-03, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5090530e3a5, moduleTitle=Lancet Haematology：硼替佐米联合帕比司他治疗复发性或难治性外周T细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5090530e3a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909573, encodeId=142e19095e39c, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Nat Commun：通过甲基化的变化来确定复发性淋巴瘤, objectType=article, longId=49744, objectId=358e49e44c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=358e49e44c2, replyNumber=0, likeNumber=80, createdTime=2016-01-24, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=358e49e44c2, moduleTitle=Nat Commun：通过甲基化的变化来确定复发性淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=358e49e44c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909570, encodeId=99b619095e0f4, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=FDA批准帕比司他用于复发性多发性骨髓瘤的治疗, objectType=article, longId=47420, objectId=3cb54e420f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cb54e420f6, replyNumber=0, likeNumber=64, createdTime=2015-03-21, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cb54e420f6, moduleTitle=FDA批准帕比司他用于复发性多发性骨髓瘤的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cb54e420f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909572, encodeId=e37f19095e2b2, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=J Dent Res：复发性口腔溃疡——细菌，你怎么看？, objectType=article, longId=49449, objectId=b1c649449d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1c649449d1, replyNumber=0, likeNumber=61, createdTime=2015-07-17, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1c649449d1, moduleTitle=J Dent Res：复发性口腔溃疡——细菌，你怎么看？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1c649449d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909584, encodeId=d88c1909584f2, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=NEJM：治疗复发性多发性硬化症，达珠单抗HYP优于干扰素β-1α, objectType=article, longId=56988, objectId=34c7569889d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34c7569889d, replyNumber=0, likeNumber=56, createdTime=2015-10-27, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34c7569889d, moduleTitle=NEJM：治疗复发性多发性硬化症，达珠单抗HYP优于干扰素β-1α, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34c7569889d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

复发性

2020-05-29

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Stroke：卒中前危险因素可严重影响复发性卒中和卒中后痴呆症

2017-05-02

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

【NCCN2016】复发性或转移性乳腺癌化疗方案汇总

2016-08-02

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

JACC：下腔静脉过滤器可减少复发性肺栓塞患者的死亡率

2016-08-21

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

NEJM：孕酮不能提高复发性流产女性的活产婴儿率

2016-10-16

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet：TIA或缺血性卒中后预防复发性卒中，越早服用阿司匹林越好

2016-06-08

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

招募患者：PD-1抗体（BMS-936558）在中国晚期或复发性实体瘤受试者中的I、II期、开放性临床研究

2016-06-11

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

JAMA：血压控制与复发性颅内出血

2016-12-23

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet Haematology：复发性多发性骨髓瘤：Elotuzumab有良好的安全性和疗效性

2016-04-03

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Stem Cells：女性复发性流产的元凶——缺乏干细胞

2016-06-19

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

FDA批准单抗药Arzerra治疗复发性CLL

2016-09-02

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

诺华白血病药物Arzerra III期临床显著改善复发性CLL无进展生存期

2016-05-07

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Neurology：高血压能够预测儿童癌症幸存者的复发性卒中？

2016-08-13

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

复发性/难治性多发性骨髓瘤患者的福音：Elotuzumab疗法

2016-04-03

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

JAMA：产毒艰难梭菌菌株M3有效预防复发性艰难梭菌感染（CDI）

2015-12-16

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

JAMA Inter Med：华法林治疗中断后复发性静脉血栓栓塞、出血和死亡风险

2015-06-01

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet Haematology：硼替佐米联合帕比司他治疗复发性或难治性外周T细胞淋巴瘤

2015-12-03

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Nat Commun：通过甲基化的变化来确定复发性淋巴瘤

2016-01-24

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

FDA批准帕比司他用于复发性多发性骨髓瘤的治疗

2015-03-21

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

J Dent Res：复发性口腔溃疡——细菌，你怎么看？

2015-07-17

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

NEJM：治疗复发性多发性硬化症，达珠单抗HYP优于干扰素β-1α

2015-10-27

科室
- - 订阅+
  - 更多科室
工具
服务